Valuation: Allied Corp.

Market Cap 1.3M 1.14M 1.05M 983K 1.85M 123M 1.89M 12.66M 4.89M 60.78M 4.9M 4.79M 211M P/E 2023
-2.13x
P/E 2024 -2.52x
Enterprise Value 7.55M 6.61M 6.1M 5.7M 10.72M 714M 10.96M 73.33M 28.31M 352M 28.36M 27.73M 1.22B EV / Sales 2023
394,366,816x
EV / Sales 2024 171,944,593x
Free-Float
52.84%
Yield 2023 *
-
Yield 2024 -
Manager TitleAgeSince
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer 71 -
Corporate Officer/Principal - 2020-05-01
Director TitleAgeSince
Director/Board Member - -
Director/Board Member - 2020-05-01
Director/Board Member - 2024-10-20
Change 5-day change 1-year change 3-year change Capi.($)
-5.00%-5.00% - - 117
+2.12%+2.84%+338.18%+19.01% 2.64B
+2.78%-8.51%+162.50%+135.71% 1.73B
-10.91%-19.72%-27.70%+109.67% 459M
-2.08%+4.44%+20.51%-6.00% 51.65M
Average -2.62%-4.53%+123.37%+64.60% 1.22B
Weighted average by Cap. +1.08%-3.60%+238.07%+68.66%

Financials

2023 2024
Net sales 0.07 0.06 0.06 0.05 0.1 6.82 0.1 0.7 0.27 3.36 0.27 0.26 11.68 0.1 0.08 0.08 0.07 0.14 9.09 0.14 0.93 0.36 4.48 0.36 0.35 15.58
Net income -10.68M -9.35M -8.62M -8.05M -15.16M -1.01B -15.5M -104M -40.03M -498M -40.09M -39.21M -1.73B -3.98M -3.48M -3.21M -3M -5.65M -376M -5.77M -38.62M -14.91M -185M -14.93M -14.6M -644M
Net Debt 5.65M 4.95M 4.56M 4.26M 8.03M 534M 8.21M 54.89M 21.19M 264M 21.22M 20.76M 915M 6.25M 5.47M 5.04M 4.71M 8.87M 591M 9.07M 60.67M 23.42M 291M 23.46M 22.95M 1.01B
Logo Allied Corp.
Allied Corp. is an international medical cannabis production company. The Company is engaged in researching, creating, and producing targeted cannabinoid health solutions. It focuses on the development of Colombian produced medicinal cannabis for patients with conditions potentially suitable for treatment. Such conditions include anxiety, insomnia, anorexia, chronic pain, epilepsy, chemotherapy-induced nausea and vomiting, post-traumatic stress disorder (PTSD), Parkinson’s disease, Tourette’s syndrome, irritable bowel syndrome (IBS) and spasticity associated with multiple sclerosis (MS) and spinal cord injury (SCI). Its core hemp-derived cannabidiol (CBD) brands are Tactical Relief Brand, Equilibrium Bio and MaXXa. The Tactical Relief brand's flagship product is a hemp-derived CBD tincture for sale in the United States. The Equilibrium Bio brand is primarily focused on hydration and recovery areas. The MaXXa brand develops natural CBD-infused cosmetics and beauty products.
Employees
-